Physician profile
James Benjamin Cox
NPI 1407879075
$17,043.42
in general payments reported to CMS, 2019-2025
20 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,956 · 2020: $560 · 2021: $4,192 · 2022: $5,472 · 2023: $1,537 · 2024: $1,809 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,545 · Food and Beverage: $2,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,544.53 |
| Food and Beverage | $2,318.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $4,371.75 | 2022-2024 | |
| Encore Medical, LP | $3,921.08 | 2019-2024 | Djo Surgical |
| Conformis, INC. | $2,360.28 | 2021 | |
| Mid-Atlantic Surgical Systems, LLC | $1,919.90 | 2019-2020 | |
| Linvatec Corporation | $1,195.33 | 2022-2023 | Biobrace 23mm |
| Peerless Surgical INC. | $989.01 | 2025 | |
| Stryker Corporation | $658.68 | 2019-2024 | Blueprint Patient Specific Instrumentation, Insignia, Augment Injectable |
| Arthrex, INC. | $462.45 | 2025 | |
| Think Surgical, INC. | $257.45 | 2024 | |
| Treace Medical Concepts, INC. | $181.53 | 2023-2024 | |
| Smith+Nephew, INC. | $172.32 | 2019-2024 | Real Intelligence |
| Alnylam Pharmaceuticals INC. | $125.00 | 2021 | |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Insight Medical Systems, INC. | $84.29 | 2023 | Arvis |
| Zimmer Biomet Holdings, INC. | $68.46 | 2023 | Persona |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthalign INC | $55.57 | 2022 | |
| Merck Sharp & Dohme LLC | $32.29 | 2025 | Verquvo |
| Depuy Synthes Sales INC. | $32.27 | 2025 | Orthovisc, Monovisc |
| Orthofix Medical, INC. | $16.43 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.33 | 2023 | Zilretta, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.